Hereditary vascular anomalies: new insights into their pathogenesis.
Identifieur interne : 003B20 ( PubMed/Checkpoint ); précédent : 003B19; suivant : 003B21Hereditary vascular anomalies: new insights into their pathogenesis.
Auteurs : J-C Tille [Suisse] ; M S PepperSource :
- Arteriosclerosis, thrombosis, and vascular biology [ 1524-4636 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Femelle, Humains, Hémangiome (anatomopathologie), Hémangiome (embryologie), Hémangiome (génétique), Lymphangiogenèse (génétique), Lymphoedème (), Lymphoedème (génétique), Malformations (embryologie), Malformations (génétique), Malformations artérioveineuses (anatomopathologie), Malformations artérioveineuses (embryologie), Malformations artérioveineuses (génétique), Mâle, Nouveau-né, Néovascularisation physiologique (génétique), Récepteur facteur croissance (génétique), Récepteur facteur croissance (physiologie), Rémission spontanée, Souris, Souris transgéniques, Substances de croissance (génétique), Substances de croissance (physiologie), Système lymphatique (malformations), Système lymphatique (métabolisme), Vaisseaux sanguins (embryologie), Vaisseaux sanguins (malformations).
- MESH :
- anatomopathologie : Hémangiome, Malformations artérioveineuses.
- embryologie : Hémangiome, Malformations, Malformations artérioveineuses, Vaisseaux sanguins.
- génétique : Hémangiome, Lymphangiogenèse, Lymphoedème, Malformations, Malformations artérioveineuses, Néovascularisation physiologique, Récepteur facteur croissance, Substances de croissance.
- malformations : Système lymphatique, Vaisseaux sanguins.
- métabolisme : Système lymphatique.
- physiologie : Récepteur facteur croissance, Substances de croissance.
- Animaux, Femelle, Humains, Lymphoedème, Mâle, Nouveau-né, Rémission spontanée, Souris, Souris transgéniques.
English descriptors
- KwdEn :
- Animals, Arteriovenous Malformations (embryology), Arteriovenous Malformations (genetics), Arteriovenous Malformations (pathology), Blood Vessels (abnormalities), Blood Vessels (embryology), Congenital Abnormalities (embryology), Congenital Abnormalities (genetics), Female, Growth Substances (genetics), Growth Substances (physiology), Hemangioma (embryology), Hemangioma (genetics), Hemangioma (pathology), Humans, Infant, Newborn, Lymphangiogenesis (genetics), Lymphatic System (abnormalities), Lymphatic System (metabolism), Lymphedema (classification), Lymphedema (genetics), Male, Mice, Mice, Transgenic, Neovascularization, Physiologic (genetics), Receptors, Growth Factor (genetics), Receptors, Growth Factor (physiology), Remission, Spontaneous.
- MESH :
- chemical , genetics : Growth Substances, Receptors, Growth Factor.
- abnormalities : Blood Vessels, Lymphatic System.
- classification : Lymphedema.
- embryology : Arteriovenous Malformations, Blood Vessels, Congenital Abnormalities, Hemangioma.
- genetics : Arteriovenous Malformations, Congenital Abnormalities, Hemangioma, Lymphangiogenesis, Lymphedema, Neovascularization, Physiologic.
- metabolism : Lymphatic System.
- pathology : Arteriovenous Malformations, Hemangioma.
- chemical , physiology : Growth Substances, Receptors, Growth Factor.
- Animals, Female, Humans, Infant, Newborn, Male, Mice, Mice, Transgenic, Remission, Spontaneous.
Abstract
Increased understanding of the mechanisms of angiogenesis and lymphangiogenesis has provided a glimpse at some of the molecules involved in the pathophysiology of hemangiomas and vascular malformations. This review focuses on recent advances in our understanding of the mechanisms of angiogenesis/lymphangiogenesis and the differentiation of arterial, venous, and lymphatic vessels. We integrate this knowledge with new data obtained from genetic studies in humans, which have revealed a number of heretofore-unsuspected candidates involved in the development of familial vascular anomalies. We present a common infantile vascular tumor, hemangioma, and then focus on hereditary familial vascular and lymphatic malformations. We also summarize transgenic mouse models for some of these malformations. It seems reasonable to believe that novel therapeutic strategies will soon emerge for the treatment of hemangiomas and vascular malformations.
DOI: 10.1161/01.ATV.0000137390.56554.df
PubMed: 15231518
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15231518Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hereditary vascular anomalies: new insights into their pathogenesis.</title>
<author><name sortKey="Tille, J C" sort="Tille, J C" uniqKey="Tille J" first="J-C" last="Tille">J-C Tille</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pathology, University Medical Center, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Clinical Pathology, University Medical Center, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pepper, M S" sort="Pepper, M S" uniqKey="Pepper M" first="M S" last="Pepper">M S Pepper</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15231518</idno>
<idno type="pmid">15231518</idno>
<idno type="doi">10.1161/01.ATV.0000137390.56554.df</idno>
<idno type="wicri:Area/PubMed/Corpus">003F63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003F63</idno>
<idno type="wicri:Area/PubMed/Curation">003F63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003F63</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003F63</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003F63</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hereditary vascular anomalies: new insights into their pathogenesis.</title>
<author><name sortKey="Tille, J C" sort="Tille, J C" uniqKey="Tille J" first="J-C" last="Tille">J-C Tille</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pathology, University Medical Center, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Clinical Pathology, University Medical Center, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pepper, M S" sort="Pepper, M S" uniqKey="Pepper M" first="M S" last="Pepper">M S Pepper</name>
</author>
</analytic>
<series><title level="j">Arteriosclerosis, thrombosis, and vascular biology</title>
<idno type="eISSN">1524-4636</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Arteriovenous Malformations (embryology)</term>
<term>Arteriovenous Malformations (genetics)</term>
<term>Arteriovenous Malformations (pathology)</term>
<term>Blood Vessels (abnormalities)</term>
<term>Blood Vessels (embryology)</term>
<term>Congenital Abnormalities (embryology)</term>
<term>Congenital Abnormalities (genetics)</term>
<term>Female</term>
<term>Growth Substances (genetics)</term>
<term>Growth Substances (physiology)</term>
<term>Hemangioma (embryology)</term>
<term>Hemangioma (genetics)</term>
<term>Hemangioma (pathology)</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Lymphangiogenesis (genetics)</term>
<term>Lymphatic System (abnormalities)</term>
<term>Lymphatic System (metabolism)</term>
<term>Lymphedema (classification)</term>
<term>Lymphedema (genetics)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Neovascularization, Physiologic (genetics)</term>
<term>Receptors, Growth Factor (genetics)</term>
<term>Receptors, Growth Factor (physiology)</term>
<term>Remission, Spontaneous</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hémangiome (anatomopathologie)</term>
<term>Hémangiome (embryologie)</term>
<term>Hémangiome (génétique)</term>
<term>Lymphangiogenèse (génétique)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (génétique)</term>
<term>Malformations (embryologie)</term>
<term>Malformations (génétique)</term>
<term>Malformations artérioveineuses (anatomopathologie)</term>
<term>Malformations artérioveineuses (embryologie)</term>
<term>Malformations artérioveineuses (génétique)</term>
<term>Mâle</term>
<term>Nouveau-né</term>
<term>Néovascularisation physiologique (génétique)</term>
<term>Récepteur facteur croissance (génétique)</term>
<term>Récepteur facteur croissance (physiologie)</term>
<term>Rémission spontanée</term>
<term>Souris</term>
<term>Souris transgéniques</term>
<term>Substances de croissance (génétique)</term>
<term>Substances de croissance (physiologie)</term>
<term>Système lymphatique (malformations)</term>
<term>Système lymphatique (métabolisme)</term>
<term>Vaisseaux sanguins (embryologie)</term>
<term>Vaisseaux sanguins (malformations)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Growth Substances</term>
<term>Receptors, Growth Factor</term>
</keywords>
<keywords scheme="MESH" qualifier="abnormalities" xml:lang="en"><term>Blood Vessels</term>
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hémangiome</term>
<term>Malformations artérioveineuses</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="embryologie" xml:lang="fr"><term>Hémangiome</term>
<term>Malformations</term>
<term>Malformations artérioveineuses</term>
<term>Vaisseaux sanguins</term>
</keywords>
<keywords scheme="MESH" qualifier="embryology" xml:lang="en"><term>Arteriovenous Malformations</term>
<term>Blood Vessels</term>
<term>Congenital Abnormalities</term>
<term>Hemangioma</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Arteriovenous Malformations</term>
<term>Congenital Abnormalities</term>
<term>Hemangioma</term>
<term>Lymphangiogenesis</term>
<term>Lymphedema</term>
<term>Neovascularization, Physiologic</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Hémangiome</term>
<term>Lymphangiogenèse</term>
<term>Lymphoedème</term>
<term>Malformations</term>
<term>Malformations artérioveineuses</term>
<term>Néovascularisation physiologique</term>
<term>Récepteur facteur croissance</term>
<term>Substances de croissance</term>
</keywords>
<keywords scheme="MESH" qualifier="malformations" xml:lang="fr"><term>Système lymphatique</term>
<term>Vaisseaux sanguins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arteriovenous Malformations</term>
<term>Hemangioma</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Récepteur facteur croissance</term>
<term>Substances de croissance</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Growth Substances</term>
<term>Receptors, Growth Factor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Female</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Remission, Spontaneous</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Mâle</term>
<term>Nouveau-né</term>
<term>Rémission spontanée</term>
<term>Souris</term>
<term>Souris transgéniques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Increased understanding of the mechanisms of angiogenesis and lymphangiogenesis has provided a glimpse at some of the molecules involved in the pathophysiology of hemangiomas and vascular malformations. This review focuses on recent advances in our understanding of the mechanisms of angiogenesis/lymphangiogenesis and the differentiation of arterial, venous, and lymphatic vessels. We integrate this knowledge with new data obtained from genetic studies in humans, which have revealed a number of heretofore-unsuspected candidates involved in the development of familial vascular anomalies. We present a common infantile vascular tumor, hemangioma, and then focus on hereditary familial vascular and lymphatic malformations. We also summarize transgenic mouse models for some of these malformations. It seems reasonable to believe that novel therapeutic strategies will soon emerge for the treatment of hemangiomas and vascular malformations.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15231518</PMID>
<DateCreated><Year>2004</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>04</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4636</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>9</Issue>
<PubDate><Year>2004</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Arteriosclerosis, thrombosis, and vascular biology</Title>
<ISOAbbreviation>Arterioscler. Thromb. Vasc. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hereditary vascular anomalies: new insights into their pathogenesis.</ArticleTitle>
<Pagination><MedlinePgn>1578-90</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Increased understanding of the mechanisms of angiogenesis and lymphangiogenesis has provided a glimpse at some of the molecules involved in the pathophysiology of hemangiomas and vascular malformations. This review focuses on recent advances in our understanding of the mechanisms of angiogenesis/lymphangiogenesis and the differentiation of arterial, venous, and lymphatic vessels. We integrate this knowledge with new data obtained from genetic studies in humans, which have revealed a number of heretofore-unsuspected candidates involved in the development of familial vascular anomalies. We present a common infantile vascular tumor, hemangioma, and then focus on hereditary familial vascular and lymphatic malformations. We also summarize transgenic mouse models for some of these malformations. It seems reasonable to believe that novel therapeutic strategies will soon emerge for the treatment of hemangiomas and vascular malformations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tille</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Pathology, University Medical Center, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pepper</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2004</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Arterioscler Thromb Vasc Biol</MedlineTA>
<NlmUniqueID>9505803</NlmUniqueID>
<ISSNLinking>1079-5642</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006133">Growth Substances</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017978">Receptors, Growth Factor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001165" MajorTopicYN="N">Arteriovenous Malformations</DescriptorName>
<QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001808" MajorTopicYN="N">Blood Vessels</DescriptorName>
<QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
<QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000013" MajorTopicYN="N">Congenital Abnormalities</DescriptorName>
<QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006133" MajorTopicYN="N">Growth Substances</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006391" MajorTopicYN="N">Hemangioma</DescriptorName>
<QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042583" MajorTopicYN="N">Lymphangiogenesis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName>
<QualifierName UI="Q000002" MajorTopicYN="N">abnormalities</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018919" MajorTopicYN="N">Neovascularization, Physiologic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017978" MajorTopicYN="N">Receptors, Growth Factor</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012075" MajorTopicYN="N">Remission, Spontaneous</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>185</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15231518</ArticleId>
<ArticleId IdType="doi">10.1161/01.ATV.0000137390.56554.df</ArticleId>
<ArticleId IdType="pii">01.ATV.0000137390.56554.df</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Suisse</li>
</country>
</list>
<tree><noCountry><name sortKey="Pepper, M S" sort="Pepper, M S" uniqKey="Pepper M" first="M S" last="Pepper">M S Pepper</name>
</noCountry>
<country name="Suisse"><noRegion><name sortKey="Tille, J C" sort="Tille, J C" uniqKey="Tille J" first="J-C" last="Tille">J-C Tille</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B20 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003B20 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:15231518 |texte= Hereditary vascular anomalies: new insights into their pathogenesis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15231518" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |